NEULAND LABORATORIES
Back to Income Statement
|
NEULAND LABORATORIES Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹1,559 Cr | ₹1,191 Cr | ₹951 Cr | ₹937 Cr | ₹763 Cr |
What is the latest Revenue of NEULAND LABORATORIES ?
Year | Revenue |
---|---|
Mar2024 | ₹1,559 Cr |
Mar2023 | ₹1,191 Cr |
Mar2022 | ₹951 Cr |
Mar2021 | ₹937 Cr |
Mar2020 | ₹763 Cr |
How is Revenue of NEULAND LABORATORIES Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹1,559 Cr | 30.84 | |
Mar2023 | ₹1,191 Cr | 25.25 | |
Mar2022 | ₹951 Cr | 1.51 | |
Mar2021 | ₹937 Cr | 22.84 | |
Mar2020 | ₹763 Cr | - |
Compare Revenue of peers of NEULAND LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NEULAND LABORATORIES | ₹15,468.4 Cr | 15.3% | -18.5% | 65.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹386,269.0 Cr | 1.6% | -8.2% | 4% | Stock Analytics | |
DIVIS LABORATORIES | ₹148,381.0 Cr | 0.9% | -8.7% | 59.9% | Stock Analytics | |
CIPLA | ₹117,803.0 Cr | 3.6% | 1.5% | -0.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹103,974.0 Cr | 3.8% | -1.4% | 13.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹94,527.1 Cr | 1.2% | -7.8% | -10.1% | Stock Analytics |
NEULAND LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NEULAND LABORATORIES | 15.3% |
-18.5% |
65.4% |
SENSEX | 1.6% |
-5.4% |
0.7% |
You may also like the below Video Courses